# Mercury Systems Inc: financial statements, quarterly

MRCY · Nasdaq · CIK 1049521 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/mrcy.md) · [Financials](/companies/mrcy/financials.md) · [Filings](/companies/mrcy/filings.md) · [Insiders](/companies/mrcy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrcy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q4 FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [181](/filings/0001049521-24-000044.md) | [197](/filings/0001049521-25-000009.md) | [208](/filings/0001049521-25-000017.md) | [249 d](/filings/0001049521-26-000045.md) | [204](/filings/0001049521-25-000062.md) | [223](/filings/0001049521-26-000006.md) | [211](/filings/0001049521-26-000024.md) | [273 d](/filings/0001049521-26-000045.md) | [225](/filings/0001049521-25-000062.md) | [233](/filings/0001049521-26-000006.md) | [236](/filings/0001049521-26-000024.md) | [290 d](/filings/0001049521-26-000045.md) |
| Cost of revenue | $m | [130](/filings/0001049521-24-000044.md) | [166](/filings/0001049521-25-000009.md) | [168](/filings/0001049521-25-000017.md) | [175 d](/filings/0001049521-26-000045.md) | [153](/filings/0001049521-25-000062.md) | [162](/filings/0001049521-26-000006.md) | [154](/filings/0001049521-26-000024.md) | [188 d](/filings/0001049521-26-000045.md) | [162](/filings/0001049521-25-000062.md) | [172](/filings/0001049521-26-000006.md) | [167](/filings/0001049521-26-000024.md) | [201 d](/filings/0001049521-26-000045.md) |
| Gross profit | $m | [50.5](/filings/0001049521-24-000044.md) | [31.5](/filings/0001049521-25-000009.md) | [40.6](/filings/0001049521-25-000017.md) | [73.2 d](/filings/0001049521-26-000045.md) | [51.8](/filings/0001049521-25-000062.md) | [60.8](/filings/0001049521-26-000006.md) | [57.1](/filings/0001049521-26-000024.md) | [84.8 d](/filings/0001049521-26-000045.md) | [62.9](/filings/0001049521-25-000062.md) | [60.6](/filings/0001049521-26-000006.md) | [69.1](/filings/0001049521-26-000024.md) | [88.6 d](/filings/0001049521-26-000045.md) |
| Research and development | $m | [31.9](/filings/0001049521-24-000044.md) | [28.5](/filings/0001049521-25-000009.md) | [21.6](/filings/0001049521-25-000017.md) | [19.4 d](/filings/0001049521-26-000045.md) | [18.4](/filings/0001049521-25-000062.md) | [21.4](/filings/0001049521-26-000006.md) | [16.0](/filings/0001049521-26-000024.md) | [11.9 d](/filings/0001049521-26-000045.md) | [13.2](/filings/0001049521-25-000062.md) | [15.4](/filings/0001049521-26-000006.md) | [15.0](/filings/0001049521-26-000024.md) | [16.2 d](/filings/0001049521-26-000045.md) |
| Selling, general and administrative | $m | [35.8](/filings/0001049521-24-000044.md) | [44.5](/filings/0001049521-25-000009.md) | [43.2](/filings/0001049521-25-000017.md) | [43.4 d](/filings/0001049521-26-000045.md) | [33.2](/filings/0001049521-25-000062.md) | [40.5](/filings/0001049521-26-000006.md) | [43.0](/filings/0001049521-26-000024.md) | [37.7 d](/filings/0001049521-26-000045.md) | [45.9](/filings/0001049521-25-000062.md) | [42.1](/filings/0001049521-26-000006.md) | [39.1](/filings/0001049521-26-000024.md) | [47.8 d](/filings/0001049521-26-000045.md) |
| Operating income | $m | [(40.2)](/filings/0001049521-24-000044.md) | [(53.9)](/filings/0001049521-25-000009.md) | [(45.7)](/filings/0001049521-25-000017.md) | [(8.0) d](/filings/0001049521-26-000045.md) | [(13.4)](/filings/0001049521-25-000062.md) | [(12.4)](/filings/0001049521-26-000006.md) | [(17.3)](/filings/0001049521-26-000024.md) | [23.6 d](/filings/0001049521-26-000045.md) | [(8.6)](/filings/0001049521-25-000062.md) | [(10.8)](/filings/0001049521-26-000006.md) | [5.2](/filings/0001049521-26-000024.md) | [14.5 d](/filings/0001049521-26-000045.md) |
| Interest expense | $m | [7.9](/filings/0001049521-24-000044.md) | [8.7](/filings/0001049521-25-000009.md) | [9.3](/filings/0001049521-25-000017.md) | [9.2 d](/filings/0001049521-26-000045.md) | [8.9](/filings/0001049521-25-000062.md) | [8.4](/filings/0001049521-26-000006.md) | [8.1](/filings/0001049521-26-000024.md) | [8.0 d](/filings/0001049521-26-000045.md) | [7.9](/filings/0001049521-25-000062.md) | [7.8](/filings/0001049521-26-000006.md) | [7.3](/filings/0001049521-26-000024.md) | [6.5 d](/filings/0001049521-26-000045.md) |
| Income tax | $m | [(13.0)](/filings/0001049521-24-000044.md) | [(18.1)](/filings/0001049521-25-000009.md) | [(12.6)](/filings/0001049521-25-000017.md) | [(7.8) d](/filings/0001049521-26-000045.md) | [(5.6)](/filings/0001049521-25-000062.md) | [(6.7)](/filings/0001049521-26-000006.md) | [(2.6)](/filings/0001049521-26-000024.md) | [2.4 d](/filings/0001049521-26-000045.md) | [(4.0)](/filings/0001049521-25-000062.md) | [(2.4)](/filings/0001049521-26-000006.md) | [0.2](/filings/0001049521-26-000024.md) | [7.0 d](/filings/0001049521-26-000045.md) |
| Net income | $m | [(36.7)](/filings/0001049521-24-000044.md) | [(45.6)](/filings/0001049521-25-000009.md) | [(44.6)](/filings/0001049521-25-000017.md) | [(10.8) d](/filings/0001049521-26-000045.md) | [(17.5)](/filings/0001049521-25-000062.md) | [(17.6)](/filings/0001049521-26-000006.md) | [(19.2)](/filings/0001049521-26-000024.md) | [16.4 d](/filings/0001049521-26-000045.md) | [(12.5)](/filings/0001049521-25-000062.md) | [(15.1)](/filings/0001049521-26-000006.md) | [(2.9)](/filings/0001049521-26-000024.md) | [0.8 d](/filings/0001049521-26-000045.md) |
| Diluted EPS | $ per share | [(0.64)](/filings/0001049521-24-000044.md) | [(0.79)](/filings/0001049521-25-000009.md) | [(0.77)](/filings/0001049521-25-000017.md) | not reported | [(0.30)](/filings/0001049521-25-000062.md) | [(0.30)](/filings/0001049521-26-000006.md) | [(0.33)](/filings/0001049521-26-000024.md) | not reported | [(0.21)](/filings/0001049521-25-000062.md) | [(0.26)](/filings/0001049521-26-000006.md) | [(0.04)](/filings/0001049521-26-000024.md) | not reported |
| Basic EPS | $ per share | [(0.64)](/filings/0001049521-24-000044.md) | [(0.79)](/filings/0001049521-25-000009.md) | [(0.77)](/filings/0001049521-25-000017.md) | not reported | [(0.30)](/filings/0001049521-25-000062.md) | [(0.30)](/filings/0001049521-26-000006.md) | [(0.33)](/filings/0001049521-26-000024.md) | not reported | [(0.21)](/filings/0001049521-25-000062.md) | [(0.26)](/filings/0001049521-26-000006.md) | [(0.04)](/filings/0001049521-26-000024.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [89.4](/filings/0001049521-23-000047.md) | [169](/filings/0001049521-24-000009.md) | [143](/filings/0001049521-24-000017.md) | [181](/filings/0001049521-25-000024.md) | [158](/filings/0001049521-24-000044.md) | [243](/filings/0001049521-25-000009.md) | [270](/filings/0001049521-25-000017.md) | [309](/filings/0001049521-26-000045.md) | [305](/filings/0001049521-25-000062.md) | [335](/filings/0001049521-26-000006.md) | [332](/filings/0001049521-26-000024.md) | [214](/filings/0001049521-26-000045.md) |
| Current assets | $m | [955](/filings/0001049521-23-000047.md) | [984](/filings/0001049521-24-000009.md) | [952](/filings/0001049521-24-000017.md) | [954](/filings/0001049521-25-000024.md) | [954](/filings/0001049521-24-000044.md) | [991](/filings/0001049521-25-000009.md) | [1,020](/filings/0001049521-25-000017.md) | [1,058](/filings/0001049521-26-000045.md) | [1,085](/filings/0001049521-25-000062.md) | [1,132](/filings/0001049521-26-000006.md) | [1,117](/filings/0001049521-26-000024.md) | [973](/filings/0001049521-26-000045.md) |
| Total assets | $m | [2,401](/filings/0001049521-23-000047.md) | [2,436](/filings/0001049521-24-000009.md) | [2,378](/filings/0001049521-24-000017.md) | [2,379](/filings/0001049521-25-000024.md) | [2,369](/filings/0001049521-24-000044.md) | [2,401](/filings/0001049521-25-000009.md) | [2,414](/filings/0001049521-25-000017.md) | [2,435](/filings/0001049521-26-000045.md) | [2,458](/filings/0001049521-25-000062.md) | [2,502](/filings/0001049521-26-000006.md) | [2,481](/filings/0001049521-26-000024.md) | [2,323](/filings/0001049521-26-000045.md) |
| Current liabilities | $m | [205](/filings/0001049521-23-000047.md) | [226](/filings/0001049521-24-000009.md) | [208](/filings/0001049521-24-000017.md) | [234](/filings/0001049521-25-000024.md) | [233](/filings/0001049521-24-000044.md) | [274](/filings/0001049521-25-000009.md) | [297](/filings/0001049521-25-000017.md) | [300](/filings/0001049521-26-000045.md) | [322](/filings/0001049521-25-000062.md) | [383](/filings/0001049521-26-000006.md) | [350](/filings/0001049521-26-000024.md) | [329](/filings/0001049521-26-000045.md) |
| Total liabilities | $m | [860](/filings/0001049521-23-000047.md) | [932](/filings/0001049521-24-000009.md) | [905](/filings/0001049521-24-000017.md) | [906](/filings/0001049521-25-000024.md) | [909](/filings/0001049521-24-000044.md) | [941](/filings/0001049521-25-000009.md) | [963](/filings/0001049521-25-000017.md) | [961](/filings/0001049521-26-000045.md) | [983](/filings/0001049521-25-000062.md) | [1,042](/filings/0001049521-26-000006.md) | [1,004](/filings/0001049521-26-000024.md) | [825](/filings/0001049521-26-000045.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,541](/filings/0001049521-25-000009.md) | [1,504](/filings/0001049521-25-000017.md) | [1,473](/filings/0001049521-25-000017.md) | [1,473](/filings/0001049521-26-000045.md) | [1,460](/filings/0001049521-26-000006.md) | [1,460](/filings/0001049521-26-000024.md) | [1,451](/filings/0001049521-26-000024.md) | [1,473](/filings/0001049521-26-000045.md) | [1,475](/filings/0001049521-26-000006.md) | [1,460](/filings/0001049521-26-000024.md) | [1,478](/filings/0001049521-26-000024.md) | [1,497](/filings/0001049521-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q4 FY2024 (2024-06-28) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q4 FY2025 (2025-06-27) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) | Q4 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(39.1)](/filings/0001049521-24-000044.md) | [45.5 d](/filings/0001049521-25-000009.md) | [(17.8) d](/filings/0001049521-25-000017.md) | [71.8 d](/filings/0001049521-26-000045.md) | [(14.7)](/filings/0001049521-25-000062.md) | [85.5 d](/filings/0001049521-26-000006.md) | [30.0 d](/filings/0001049521-26-000024.md) | [38.1 d](/filings/0001049521-26-000045.md) | [2.2](/filings/0001049521-25-000062.md) | [51.6 d](/filings/0001049521-26-000006.md) | [6.4 d](/filings/0001049521-26-000024.md) | [42.2 d](/filings/0001049521-26-000045.md) |
| Capital expenditure | $m | [8.0](/filings/0001049521-24-000044.md) | [8.0 d](/filings/0001049521-25-000009.md) | [7.9 d](/filings/0001049521-25-000017.md) | [10.3 d](/filings/0001049521-26-000045.md) | [6.2](/filings/0001049521-25-000062.md) | [3.6 d](/filings/0001049521-26-000006.md) | [5.9 d](/filings/0001049521-26-000024.md) | [4.1 d](/filings/0001049521-26-000045.md) | [6.5](/filings/0001049521-25-000062.md) | [5.9 d](/filings/0001049521-26-000006.md) | [8.3 d](/filings/0001049521-26-000024.md) | [13.6 d](/filings/0001049521-26-000045.md) |
| Share repurchases | $m | [0.0](/filings/0001049521-23-000047.md) | [0.0 d](/filings/0001049521-25-000009.md) | [0.0 d](/filings/0001049521-25-000017.md) | [0.0 d](/filings/0001049521-26-000045.md) | not reported | not reported | [0.0 d](/filings/0001049521-26-000024.md) | [0.0 d](/filings/0001049521-26-000045.md) | not reported | not reported | [0.0 d](/filings/0001049521-26-000024.md) | [0.0 d](/filings/0001049521-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-30) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-29) | Q2 FY2024 (2023-12-29) | Q3 FY2024 (2024-03-29) | Q1 FY2025 (2024-09-27) | Q2 FY2025 (2024-12-27) | Q3 FY2025 (2025-03-28) | Q1 FY2026 (2025-09-26) | Q2 FY2026 (2025-12-26) | Q3 FY2026 (2026-03-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.9](/filings/0001049521-23-000047.md) | [56.3](/filings/0001049521-24-000009.md) | [56.9](/filings/0001049521-24-000017.md) | [57.1](/filings/0001049521-24-000044.md) | [57.4](/filings/0001049521-25-000009.md) | [57.7](/filings/0001049521-25-000017.md) | [58.3](/filings/0001049521-25-000062.md) | [58.6](/filings/0001049521-26-000006.md) | [58.7](/filings/0001049521-26-000024.md) | [59.2](/filings/0001049521-25-000062.md) | [59.4](/filings/0001049521-26-000006.md) | [59.4](/filings/0001049521-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 60,136,133 at 2026-07-31, from the cover of the [10-K filed 2026-08-18](/filings/0001049521-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.